Avandia's Future Still Bleak?

(MedPage Today) -- An FDA panel recommendation to loosen restrictions on the diabetes drug rosiglitazone (Avandia) isn't likely to affect how -- or whether -- doctors prescribe it, according to experts interviewed by MedPage Today.

http://www.medpagetoday.com/Endocrinology/Diabetes/39707

Source: MedPage Today Cardiovascular - June 8, 2013 Category: Cardiology Source Type: news